P468: Microscopic colitis: systematic analysis of 200 adult patients with a mean follow-up of 4 yearsECCO '18 Vienna
2018
P469: Self-reported cutaneous side effects of anti-TNF therapy in inflammatory bowel disease patientsECCO '18 Vienna
2018
P470: Improving IBD-related pregnancy knowledge with a specialised preconception and pregnancy in IBD clinicECCO '18 Vienna
2018
P471: Clinical characteristics and complications in hospitalised elderly patients with ulcerative colitis in a real-world specialised hospitalECCO '18 Vienna
2018
P472: Impact of anti-TNF-alfa therapy on colectomy rates and indications for surgery in Ulcerative Colitis: Comparison of two patient cohorts from 2005 to 2007 and 2014 to 2016ECCO '18 Vienna
2018
P473: Contrasting the use of 5-ASA in patients with Ulcerative Colitis and Crohn's Disease: A cross-sectional analysis at a tertiary care IBD clinicECCO '18 Vienna
2018
P474: Efficacy and safety of anti-TNF and vedolizumab in liver transplant recipients with inflammatory bowel disease (IBD)ECCO '18 Vienna
2018
P475: High prevalence of severe liver fibrosis in patients with longstanding IBDECCO '18 Vienna
2018
P476: Using small bowel and colon video capsule endoscopy to optimise Crohn’s disease therapy may improve patient quality of lifeECCO '18 Vienna
2018
P477: The efficacy of adalimumab for the treatment of Korean patients with ulcerative colitis and predictors of response: Preliminary resultsECCO '18 Vienna
2018
P478: Treatment with ferric maltol associated with improvements in quality of life for IBD patients with iron deficiency anaemiaECCO '18 Vienna
2018
P479: Quality of care and outcomes in a tertiary hospital inflammatory bowel disease (IBD) centre: Monitoring and treatment algorithms during follow-upECCO '18 Vienna
2018
P480: Effectiveness of anti-inflammatory therapy in immune checkpoint inhibitor-induced diarrhoea/colitisECCO '18 Vienna
2018
P481: Induction treatment with subcutaneous rather than intravenous ustekinumab is associated with comparable circulating drugs levels and early clinical responseECCO '18 Vienna
2018
P482: Transanal minimally invasive proctectomy (TaMIP) in patients with inflammatory bowel diseases (IBD) within the TaTME international databaseECCO '18 Vienna
2018
P484: Infliximab and vedolizumab show a different effect on clot formation in inflammatory bowel disease patientsECCO '18 Vienna
2018